Ulinastatin

Ulinastatin has been studied in 5 papers since 2016: 2 trials in people, 2 reviews. The newest paper, Jul 11, 2023: “Effects of anesthetic adjunctive agents on postoperative cognitive dysfunction in elderly patients undergoing noncardiac surgery: A Bayesian network meta-analysis”.

Intervention

5 papers study it12 findingsUpdated

See all 5 papers on ulinastatin

At a glance

Independent labs found the same change in people. 3 independent labs in 1 country; 1 trial, none about aging.

“The U group had a lower incidence of POCD than C group (23.7 % versus 45.9 %, P = 0.043).”
Effects of ulinastatin on early postoperative cognitive function after one-lung ventilation surgery in elderly patients receiving neoadjuvant chemotherapyMetabolic brain disease2016doi:10.1007/s11011-016-9926-7

None of its findings points the other way.

Humans: replicated by independent labs. Cells, worms or flies and mice: nothing yet.
  • 3 independent labs in 1 country
  • 1 trial, none about aging
  • Funders: Beijing Municipal Administration of Hospitals and 8 more
  • 1 of 1 trial sponsored by its developers
  • Human trial2

Studies in people

3 studies gave ulinastatin to people and measured what changed.

What changedDesignPeopleSource

down: Prevents postoperative cognitive dysfunctionOR = 0.28, 95% CI 0.10 to 0.71

Review of trialselderlyOlder adultsBrain and behavior, Jul 11, 2023

down: Decreases postoperative cognitive dysfunction16% vs. 43%, χ2 = 5.079, P = 0.024

down: Inhibits lipopolysaccharide translocation

Randomized trialpostoperative days 1 and 260 peopleelderlyOlder adults; elderly patients undergoing spinal surgery; total intravenous anesthesiaFrontiers in pharmacology, Oct 9, 2018

down: Decreases postoperative cognitive dysfunction23.7% vs 45.9% incidence

down: Decreases S-100β protein

down: Decreases IL-6

Randomized trialpostoperative days 1 to 380 peopleelderlyOlder adults; after one-lung ventilation surgery with neoadjuvant chemotherapyMetabolic brain disease, Nov 9, 2016

What did studies of ulinastatin find?

6

Studies of ulinastatin measured 6 outcomes; the most studied are postoperative cognitive dysfunction (4 studies) and inflammation (3).

Postoperative cognitive dysfunction

downin humans4OR 0.28

4 studies
  1. Ulinastatin prevents postoperative cognitive dysfunction in humans (compared with dexmedetomidine) (OR = 0.28, 95% CI 0.10 to 0.71).

    “ulinastatin may be more effective in preventing POCD than dexmedetomidine [odds ratio (OR) = 0.28, 95% confidence interval (CI) = (0.10, 0.71)]”

    Human trialcompared with dexmedetomidine

    Effects of anesthetic adjunctive agents on postoperative cognitive dysfunction in elderly patients undergoing noncardiac surgery: A Bayesian network meta-analysis

    Brain and behavior

  2. Ulinastatin decreases postoperative cognitive dysfunction in humans (elderly patients undergoing spinal surgery; total intravenous anesthesia) (16% vs. 43%, χ2 = 5.079, P = 0.024).

    “Ulinastatin infusion significantly reduced the incidence of POCD in elderly patients undergoing spine surgery”

    Human trialelderly patients undergoing spinal surgery; total intravenous anesthesia10,000 units/kg then 5000 units/kg

    Ulinastatin May Significantly Improve Postoperative Cognitive Function of Elderly Patients Undergoing Spinal Surgery by Reducing the Translocation of Lipopolysaccharide and Systemic Inflammation

    Frontiers in pharmacology

  3. Ulinastatin decreases postoperative cognitive dysfunction in humans after one-lung ventilation surgery with neoadjuvant chemotherapy (23.7% vs 45.9% incidence).

    “The U group had a lower incidence of POCD than C group (23.7 % versus 45.9 %, P = 0.043).”

    Human trialafter one-lung ventilation surgery with neoadjuvant chemotherapy10,000 U/kg before anesthesia, then 5000 U/kg dailypostoperative days 1 to 3n = 80

    Effects of ulinastatin on early postoperative cognitive function after one-lung ventilation surgery in elderly patients receiving neoadjuvant chemotherapy

    Metabolic brain disease

  4. Ulinastatin prevents postoperative cognitive dysfunction in humans (perioperative use in elderly patients under general anesthesia).

    “effectively prevent the occurrence of POCD and reduce its incidence”

    Reviewperioperative use in elderly patients under general anesthesia

    Efficacy and safety of ulinastatin on cognitive dysfunction after general anesthesia in elderly patients: A protocol for systematic review and meta-analysis

    Medicine

More on Postoperative cognitive dysfunction

Inflammation

downin humans3

3 studies
  1. Ulinastatin inhibits inflammation in humans (compared with control group following surgery).

    “The elderly patients in ulinastatin group exhibited lower serum LPS, IL-6, CRP, and MMP-9 concentrations”

    Human trialcompared with control group following surgery

    Ulinastatin May Significantly Improve Postoperative Cognitive Function of Elderly Patients Undergoing Spinal Surgery by Reducing the Translocation of Lipopolysaccharide and Systemic Inflammation

    Frontiers in pharmacology

  2. Ulinastatin decreases inflammation in humans following surgery.

    “patients in the ulinastatin group have lower levels of TNF-α, S100β, CRP, and IL-6 and higher level of IL-10 in serum following surgery”

    Reviewfollowing surgeryserum

    Effect of Ulinastatin on Early Postoperative Cognitive Dysfunction in Elderly Patients Undergoing Surgery: A Systemic Review and Meta-Analysis

    Frontiers in neuroscience

  3. Ulinastatin decreases inflammation in humans (perioperative use in elderly patients under general anesthesia).

    “The use of Ulinastatin in perioperative period can significantly reduce the inflammatory level of elderly patients after general anesthesia”

    Reviewperioperative use in elderly patients under general anesthesia

    Efficacy and safety of ulinastatin on cognitive dysfunction after general anesthesia in elderly patients: A protocol for systematic review and meta-analysis

    Medicine

More on Inflammation

Lipopolysaccharide translocation

downin humans1

1 study
  1. Ulinastatin inhibits lipopolysaccharide translocation in humans (elderly patients undergoing spinal surgery).

    “Systemic inflammation and translocation of LPS were inhibited by the infusion of ulinastatin”

    Human trialelderly patients undergoing spinal surgery

    Ulinastatin May Significantly Improve Postoperative Cognitive Function of Elderly Patients Undergoing Spinal Surgery by Reducing the Translocation of Lipopolysaccharide and Systemic Inflammation

    Frontiers in pharmacology

IL-10

upin humans1

1 study
  1. Ulinastatin increases IL-10 in humans (on postoperative day 3).

    “On postoperative day 3, compared with C group, the level of CRP in U group was lower, while that of IL-10 was higher.”

    Human trialon postoperative day 310,000 U/kg before anesthesia, then 5000 U/kg dailypostoperative days 1 to 3n = 80

    Effects of ulinastatin on early postoperative cognitive function after one-lung ventilation surgery in elderly patients receiving neoadjuvant chemotherapy

    Metabolic brain disease

More on IL-10

IL-6

downin humans1

1 study
  1. Ulinastatin decreases IL-6 in humans (postoperative).

    “The postoperative concentrations of S-100β protein, IL-6, and CRP in U group were lower than those in C group.”

    Human trialpostoperative10,000 U/kg before anesthesia, then 5000 U/kg dailypostoperative days 1 to 3n = 80

    Effects of ulinastatin on early postoperative cognitive function after one-lung ventilation surgery in elderly patients receiving neoadjuvant chemotherapy

    Metabolic brain disease

More on IL-6

S-100β protein

downin humans1

1 study
  1. Ulinastatin decreases S-100β protein in humans (postoperative).

    “The postoperative concentrations of S-100β protein, IL-6, and CRP in U group were lower than those in C group.”

    Human trialpostoperative10,000 U/kg before anesthesia, then 5000 U/kg dailypostoperative days 1 to 3n = 80

    Effects of ulinastatin on early postoperative cognitive function after one-lung ventilation surgery in elderly patients receiving neoadjuvant chemotherapy

    Metabolic brain disease

More on S-100β protein

What is ulinastatin linked with?

1

Studies link ulinastatin with postoperative cognitive dysfunction.

Postoperative cognitive dysfunction

downin humans1RR 0.29

1 study
  1. Ulinastatin lowers the risk of postoperative cognitive dysfunction in elderly patients undergoing surgery (RR = 0.29, 95% CI 0.21-0.41).

    “ulinastatin significantly reduced the incidence of POCD [risk ratio (RR) = 0.29, 95% CI 0.21-0.41, test of RR = 1: Z = 7.05, p < 0.00001]”

    Reviewin elderly patients undergoing surgery

    Effect of Ulinastatin on Early Postoperative Cognitive Dysfunction in Elderly Patients Undergoing Surgery: A Systemic Review and Meta-Analysis

    Frontiers in neuroscience

More on Postoperative cognitive dysfunction

Who is developing ulinastatin?

1 company: Techpool Bio-Pharma.

Companies
  • Techpool Bio-PharmaPhase 1ulinastatin

Trial sponsors

Latest